cytarabine (Arac) is the mainstay chemotherapy for acute myeloid leukemia (AML). Whereas initial treatment with Arac is usually successful, most AML patients tend to relapse, and Arac treatmentinduced mutagenesis may contribute to the development of chemo-resistant leukemic clones. We show here that whereas the high-fidelity replicative polymerase Polδ is blocked in the replication of Arac, the lower-fidelity translesion DNA synthesis (TLS) polymerase Polη is proficient, inserting both correct and incorrect nucleotides opposite a template Arac base. furthermore, we present high-resolution crystal structures of human polη with a template Arac residue positioned opposite correct (G) and incorrect (A) incoming deoxynucleotides. We show that polη can accommodate local perturbation caused by the AraC via specific hydrogen bonding and maintain a reaction-ready active site alignment for insertion of both correct and incorrect incoming nucleotides. taken together, the structures provide a novel basis for the ability of polη to promote Arac induced mutagenesis in relapsed AML patients.
Structure determination. We crystalized the human Polη catalytic core (residues 1 to 432) with a template-primer 12/8-mer (5′-CAT(AraC)ACAGTGCT-3′/5′-AGCACTGT-3′) and non-reactive dGTP analog dGMPNPP. We refined this cognate ternary complex structure with the G opposite the AraC template residue to 2.4 Å resolution and to R free of 21.4% and R work of 17.7%.
To visualize the misinsertion of an A opposite the template AraC we first tried, unsuccessfully, to grow crystals with the same template-primer DNA as described above for the cognate complex while replacing dGMPNPP by dAMPNPP. We chose to facilitate crystallization by modifying the DNA duplex within the polymerase-unbound end and introduced a mismatch to loosen the end-to-end DNA packing interactions. We then succeeded with overall arrangement. In both AraC-containing ternary complexes ( Figs 3A and 4A) , Polη encircles the template-primer with its palm (residues 1-13 and 90-238), fingers (residues 17-87), thumb (residues 241-301) domains as well as the PAD (polymerase associated domain; residues 319-432). The palm domain carries the catalytic residues Asp13, Asp115, and Glu116, while the fingers domain lies above the templating AraC base (Figs 3B and 4B) . The thumb and the PAD grasp the template-primer DNA duplex at opposite sides, from the minor and major groove surfaces, respectively (Figs 3A and 4A). As in the ternary structures of Polη with unmodified DNA templates 36 , the sugar moieties of the incoming dGMPNPP and dAMPNPP nucleotides are packed against the aromatic ring of Phe 18, which acts as a "streric gate" for the exclusion of ribonucleotides. The triphosphate moieties of dGMPNPP and dAMPNPP are interlaced between the fingers and palm domain and assume the same conformation as in the unmodified Polη complexes (Figs 3B,C and 4B,C).
insertion of correct G opposite Arac. The AraC base pairs with the G base of incoming dGMPNPP with the expectant Watson-Crick (W-C) geometry ( Fig. 3E ). However, the C1′-C1′ distance across the base pair is ~10.71 Ả, as compared to 10.5 Ả for an ideal W-C base pair. Also, the AraC base is tilted by ~30°, which negatively impacts its stacking with the adjacent bases on the template strand ( Fig. 3D ). The AraC sugar assumes the C1′-exo conformation rather than the C2′-endo conformation observed in Polη structures with unmodified DNA. C1′-exo is one of the preferred sugar conformations for arabinonucleosides 37 , and it appears to be further stabilized in the Polη active by a hydrogen bond between the "extra" 2′-OH on the AraC sugar and the main chain [C*] = dC or AraC 23 22 21 20 A amide of Asn324 of the polymerase (Fig. 3D ). Together, this lends to further local adjustments in the AraC sugar and the active site residues (when compared to the unmodified structures), including an ~1.0 Ả shift in the O4′ atom of the AraC sugar and a relocation of the AraC phosphate group by ~1.4 Ả, with the latter now in a position to make a hydrogen bonds with amide group of Asn324 and giving rise to an unusual intramolecular hydrogen bond between the C2′-OH and the O5′ atoms of AraC ( Fig. 3D ). Also, in contrast to the unmodified structures, the side chain of Gln38 forms a hydrogen bond with the O 2 atom of the AraC base instead of the O4′ atom the sugar, and Arg61 (unique to Polη) adopts a single rotameric conformation to stabilize the binding of the incoming nucleotide rather than multiple conformations. In spite of these local rearrangements, the Polη active site is well adapted for the incorporation of the incoming nucleotide opposite template AraC. Analogous to the unmodified structure, the catalytic Mg A 2+ ion is coordinated by the 3′-OH of the primer terminus, the α-phosphate group oxygen atom of dGMPNPP, the carboxylates of Asp115 (2.14 Ả), Glu116 (1.89 Ả), and Asp13 (2.09 Ả), and a water molecule ( Fig. 3C ). Mg B 2+ is ligated by the dGMPNPP βand γ-phosphates, the carboxylates of Asp13 (1.95 Ả) and Asp115 (2.18 Ả) and by the backbone carboxyl oxygen of Met14 (2.34 Ả). Importantly, the 3′-OH of the primer terminus is at the reaction-ready www.nature.com/scientificreports www.nature.com/scientificreports/ distance of 3.41 Ả from the α-P atom of dGMPNPP. Thus, despite local adjustments in how AraC is accommodated in the Polη active site, the polymerase is well poised for the incorporation of G opposite template AraC.
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insertion of mismatched A opposite Arac. AraC forms a wobble base pair with the A base of the incom-
ing dAMPNPP (Fig. 4E ). From the observed geometry, the adenine base of the dAMPNPP is likely protonated at the N1 position, resulting in a 2.7 Å hydrogen bond with the acceptor O 2 atom of the AraC base ( Fig. 5A) . A second hydrogen bond forms between the N3 acceptor group of the AraC and the donor atoms N 6 (3.3 Å) of dAMPNPP. The overall geometry is similar that of a C:A mismatch in a free DNA duplex 38 , including ~0.65 Ả shifts in the AraC/C and dAMPNPP/A bases towards the major and minor grooves of the DNA, respectively, when compared to a W-C base pair. Because of the wobble base pair, the AraC residue is too far away to make contacts with the side-chain of Gln38 and the base is untilted and maintains stacking with the adjacent DNA bases (Fig. 4D ). The C1′-C1′ distance across the base pair is 10.33 Ả, typical for wobble base pair.
Despite these local adjustments to accommodate a mismatched AraC-A base pair, the Polη active site is relatively unperturbed and the 3′-OH of the primer terminus is at the reaction-ready 3.55 Ả distance from the α-P atom of dAMPNPP ( Fig. 4B,C) . Also, as in the cognate complex, the AraC sugar pucker is C1′-exo, the Asn324 www.nature.com/scientificreports www.nature.com/scientificreports/ side-chain forms a direct hydrogen bond with the 2′-OH of the sugar, and the phosphate group of the AraC is positioned to make contact with Asn324 (though, too far away for an intramolecular hydrogen bond between the C2′-OH and the O5′ atoms) ( Fig. 4D ).
Discussion
AraC has remained the mainstay chemotherapy for AML for over 40 years [1] [2] [3] . The incorporation of AraC into the genome results in blockage of the high-fidelity polymerases at the sites of incorporation and necessitates the participation of TLS Pols in its subsequent bypass. We show here that human Polη can efficiently bypass AraC embedded in a DNA template strand by incorporating cognate G as well as noncognate deoxynucleotides (predominantly an A) opposite the lesion. We provide a structural basis for this ability of human Polη to insert both a correct (G) and an incorrect (A) deoxynucleotide opposite AraC. Surprisingly, despite very different base pair geometries, W-C for AraC-G and wobble for AraC-A, the plasticity of the Polη active site is such that it permits the catalytic residues to remain aligned for the insertion of correct G as well as mutation-inducing A opposite AraC.
Although chemotherapy with AraC is very successful for newly diagnosed AML patients, the majority of patients tend to relapse. Thus, treatment of AML with AraC is in many ways a double-edged sword. Studies of AraC exposure in human TK6 cells have established AraC as a mutagen 7 , and relapsed patients have been shown to carry a higher AraC-induced mutation burden [7] [8] [9] [10] . Notably, AraC is suggested to be a base substitution mutagen because DNA mismatch repair (MMR) deficient cells had higher mutation frequencies than their MMR-proficient counterparts 7 . Based on our studies, part of this mutation burden likely arises from error-prone replication of AraC by human Polη. Polη is particularly effective in inserting A opposite AraC, though mutagenic C and T also get inserted. The insertion of A does not perturb the active site sufficiently to preclude the catalytic reaction. The putative primer 3′OH remains well positioned for a nucleophilic attack on the α-P atom of the mismatched nucleotide. This was of surprise because a T:G wobble base pair by contrast, which is often formed www.nature.com/scientificreports www.nature.com/scientificreports/ by Polη to promote somatic hypermutation 39 (Fig. 5B ) leads to a primer 3′-OH that is predominantly in a nonproductive conformation 39 .
Taken together, Polη emerges from our studies as capable of promoting AraC induced mutations during chemotherapy. It has also been shown that AML relapse can originate from leukemia clones that exist prior to chemotherapy and have greater transcriptional plasticity 40 . It would be interesting to evaluate if these highly adaptive clones upregulate expression of Polη to promote survival during the second round of treatment.
Methods preparation of proteins for biochemical studies.
To express full-length human Polη in yeast, the PolH cDNA in clone GS27149 41 was amplified by PCR and cloned in frame with the Glutathione S-transferase gene under control of a galactose inducible phosphoglycerate kinase (PGK) promoter in plasmid pBJ842 42 , generating plasmid pR30.186. The integrity of PCR generated regions was confirmed by sequencing. Yeast strain YRP654 was transformed with pR30.186 and human Polη protein was expressed and purified as described 43 . To produce human full-length four-subunit Polδ holoenzyme, the p125, p50, p66 and p12 subunits of Polδ were co-expressed in yeast from 3 plasmids. The PolD1 cDNA encoding the p125 catalytic subunit was amplified by PCR from a baculovirus expression vector 44 (gift from Dr. Ellen Fanning). The PolD2, PolD3 and PolD4 cDNAs encoding the p50, p66 and p12 subunits, respectively, were each amplified by PCR from baculovirus expression vectors obtained from Dr. Jerard Hurwitz. Each cDNA was confirmed by sequencing. The PolD1 cDNA was cloned in frame with a Flag-metal affinity tag in plasmid pPM1257, which harbors the yeast leu2d gene, generating pBJ1604 plasmid. The PolD2 cDNA was cloned in frame with Glutathione S-transferase gene in plasmid pBJ842 and the PolD3 gene was expressed natively by cloning in plasmid pBJ1179, which carries the Trp1 gene. The GST-PolD2 expression cassette was then subcloned into the PolD3 expression plasmid generating the dual GST-PolD2/PolD3 Trp1 yeast expression plasmid, pBJ1599. PolD4 was expressed natively by cloning the cDNA into the Ura3 containing plasmid pPM271, generating pBJ1601 plasmid. Yeast strain YRP654 was co-transformed with plasmids pBJ1604, pBJ1599 and pBJ1601 and colonies were selected for on synthetic yeast media lacking leucine, uracil and tryptophan. Protein expression was carried out as described 42 . The hPolδ holoenzyme was purified using a standard protocol utilizing glutathione Sepharoase (GE biotech) and anti-Flag M2 Agarose (Sigma) affinity purification steps 42 . All tags were removed from the respective fusion proteins by PreScission protease. primer extension. DNA substrates consisted of a 75-mer template DNA template (5′-AGCTACCATG CCTGCCTCAA GAATTCGTAT XATGCCTACA CTGGAGTACC GGAGCATCGT CGTGACTGGG AAAAC-3′, where X denotes either dC or AraC) and a 5′-32 P labeled 23-mer primer (5′-CTCCGGTACT CCAGTGTAGG CAT-3′). Thus, this template-primer creates a "standing start" substrate that allows the first nucleotide to be www.nature.com/scientificreports www.nature.com/scientificreports/ incorporated either opposite the unmodified dC or AraC and it has a 31-mer 5′-template overhang that permits synthesis of a 54-mer long full extension reaction product (an 11-mer 3′-template overhang remains single stranded). The 75-mer AraC-modified template was purchased from Midland Certified Reagent Company. DNA 5′-32 P-radiolabeled primer was mixed with the unmodified dC-or AraC-containing template in 1:1.5 molar ratio and annealed by heating the solution to 95 °C and allowing it to cool to room temperature for several hours. The DNA polymerase assay was performed as described previously 42 . Reactions (5 μL final volume) contained 25 mM tris-HCl pH 7.5, 0.1 mg/ml BSA, 10% glycerol, 1 mM DTT, 5 mM MgCl 2 , 10 nM DNA substrate, and 25 μM of either dATP, dGTP, dTTP, or dCTP or all four dNTPs combined. Human Polη and Polδ holoenzyme were each assayed at a final concentration of 0.5 nM. Reactions were initiated by the addition of 1 μL of 2.5 nM DNA polymerase solution in 5x reaction buffer (125 mM Tris-HCl pH 7.5, 0.5 mg/ml BSA, 5 mM DTT) to 4 μl of DNA substrate/dNTP/Mg 2+ /glycerol mixture and carried out for 10 minutes at 37 °C before terminating with 6 volumes of loading buffer (95% formamide, 0.06% xylene cyanol and 0.06% bromophenol blue). Reaction products were separated on 15% polyacrylamide gel prepared with Tris-Boric Acid-EDTA (TBE) buffer and containing 8 M urea. Gels were dried and products were visualized by phosphorimaging on a Typhoon FLA7000 (GE biotech). preparation of protein for crystallization. An N-terminal His 6 tagged catalytic core of human Polη (residues 1-432) with a C406M mutation was overexpressed in Escherichia coli and purified as previously described 36, 45 . Briefly, the His 6 tag was removed by overnight incubation with PreScission protease, and the protein was purified by ion-exchange (MonoS) chromatography followed by size-exclusion (Superdex 75). The protein was concentrated to ~1.3 mg/ml in 25 mM tris (pH 8.0), 250 mM NaCl, and 2 mM tris(2-carboxyethyl) phosphate (TCEP) and stored in aliquots at −80 °C. crystallization. The crystals of the ternary complex with the correct incoming guanine opposite the template AraC residue were obtained by incubating the human Polη catalytic core with a DNA template-primer (5′-CAT(AraC)ACAGTGCT-3′/5′-AGCACTGT-3′) (TriLink Biotechnologies Inc. and Glen Research, Inc, respectively) in the presence of non-hydrolysable dGTP analog dGMPNPP (2′-deoxyguanosine-5′[(α,β)-imido] triphosphate, Jena Bioscience) by the hanging drop method against a reservoir solution containing 0.1 M MES pH 6.0 buffer and 10-14% PEG1500. The crystal growth and harvesting were performed as described in our study of AraC incorporation into the primer strand by Polη 46 . Briefly, the template-primer DNAs were annealed by heating for 5 min at 90 °C and slowly cooled to 4 °C and then mixed with Polη in a 1.2:1 molar ratio to ~0.02 mM concentration of the complex in 25 mM tris (pH 8.0), 125 mM NaCl and 1 mM TCEP. The complex was incubated on ice for 20 minutes and then concentrated with Amicon Ultra centrifugal filter (cut-off 3KDa) to a final complex concentration of ~0.105 mM at 4 °C. dGMpNPP and MgCl 2 were then added to the complex to 2 mM and 4 mM concentrations, respectively. The resulting complex was either used for crystallization immediately or stored in aliquots at −80 °C. In both cases, the complex was centrifuged at 8,000 rpm for 2 min at 4 °C prior to crystallization. The hanging crystallization drop was formed by mixing 1 μL of the complex with 1 μL of the reservoir solution on a siliconized coverslip and the crystals were grown at 20 °C. To produce larger diffraction-quality crystals, a round of microseeding with Seed Bead kit (Hampton Research) was performed. The crystals were scooped out of crystallization drops in CryoLoops (Hampton Research) and cryoprotected in the reservoir solution increased to 24% PEG1500 followed by additional stepwise supplementation with 5%, 10% and 20% glycerol. The cryoprotected crystals were flash frozen in liquid nitrogen for X-ray data collection.
To produce ternary complex crystals visualizing the insertion of an A base opposite the template AraC, we used the template-primer (5′-CAT(AraC)ACAGTGCG-3′/5′-TGCACTGT-3′) DNA and dAMPNPP (2′-Deoxyadenosine-5′-[(α,β)-imido]triphosphate, Jena Bioscience). The crystallization drops were set up, and crystal grown and harvested as described above.
Structure determination and refinement. The X-ray diffraction data were collected at the NSLS X25 beam line at the Brookhaven National Laboratory and at the 24-ID NE-CAT beamline at Advanced Photon Source in Chicago. The data from the NSLS X25 beam line were processed and scaled using the HKL2000 suite 47 and the data from the 24-ID NE-CAT beamline were processed by RAPD pipeline (http://necat.chem.cornell.edu/). We solved the structure of the Polη cognate ternary complex with the correct G opposite the template AraC base by the molecular replacement method (Phaser) 48 in the CCP4 program package 49 using the Polη extension ternary complex structure with AraC residue at the 3′-end of the primer strand (PDB ID: 6D0Z) as a search model 46 . The model building, including substitution of the DNA sequence, was finished manually in Coot 50 based on the electron density maps calculated in PHENIX Refine 51 . The final model was refined in PHENIX Refine to 2.4 Å resolution 51 and belongs to P6 1 space group with unit cell dimensions of a = b = 98.2 Å, c = 81.3 Å, α = β = 90°, and γ = 120.0°. The structure is refined to R free of 21.4% and R work of 17.7% and consists of one Polη molecule (residues 1 to 432), one DNA template (residues 2 to 12), one DNA primer (residues 1 to 8), one dGMNPP, two Mg 2+ ions and a total of 122 solvent molecules. The placement and conformation of the AraC residue was verified using simulated annealing omit maps calculated in PHENIX 51 with the AraC omitted from the model before heating to 2,000 K and then slowly cooling.
The crystals with the incoming A opposite the template AraC diffracted to 2.09 Å resolution and belong to P6 1 space group with unit cell dimensions of a = b = 99.0 Å, c = 81.8 Å, α = β = 90°, and γ = 120.0°. We solved the structure by MR using the ternary complex with the correct incoming nucleotide (described above) as a search model. The structure is refined to R free of 23.8% and R work of 19.6% and consists of one Polη molecule (residues 1 to 432), one DNA template (residues 2 to 12), one DNA primer (residues 1 to 8), one dGPMNPP, two Mg 2+ ions and a total of 234 solvent molecules.
The crystal data, together with the data collection and refinement statistics, are summarized in Table 1 .
